Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region
Open Access
- 25 April 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pneumonia
- Vol. 9 (1), 1-9
- https://doi.org/10.1186/s41479-017-0031-4
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniaeinfection in Fukuoka, JapanBMC Infectious Diseases, 2013
- Providing Impetus, Tools, and Guidance to Strengthen National Capacity for Antimicrobial Stewardship in Viet NamPLoS Medicine, 2013
- Key informant interview on antimicrobial resistance (AMR) in some countries in the western pacific regionGlobalization and Health, 2013
- Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?BMC Infectious Diseases, 2012
- Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) StudyAntimicrobial Agents and Chemotherapy, 2012
- Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS studyTropical Medicine & International Health, 2011
- Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community studyBMC Infectious Diseases, 2010
- Reduced Vancomycin Susceptibility inStaphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsClinical Microbiology Reviews, 2010
- Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trialThe Lancet, 2008
- Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study)BMJ, 2008